Development and Empirical Research on a Virtual Simulation Training System for Clinical Nurses Responding to Bioterrorist Attacks
- P (Population): Participants in a clinical nursing training program at a certain university
- I (Intervention): Theoretical instruction + training using a self-developed virtual simulation platform for emergency response to bioterrorism incidents; intervention duration: 4 weeks
- C (Comparison): Traditional in-person training (theoretical lectures + practical exercises)
- O (Outcome): Assessment of nursing staff's biosafety response capabilities using the Clinical Nurse Biosafety Response Scale
Aperçu de l'étude
Statut
Intervention / Traitement
Description détaillée
This study aims to validate the effectiveness of a virtual simulation training system for emergency response to bioterrorism incidents in enhancing the biosafety response capabilities of clinical nursing staff. An asynchronous controlled trial was conducted, utilizing two consecutive training sessions for clinical nursing staff at a university; participants in the first session were assigned to the control group, while those in the second session were assigned to the intervention group. The control group received traditional in-person training (combining theoretical instruction with practical exercises), while the intervention group underwent training that combined theoretical instruction with the virtual simulation training platform developed for this study. The intervention duration was 4 weeks for both groups, and assessments were conducted before and after the intervention using the Clinical Nurse Biosafety Response Scale.
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Ning Zha Ning Zha, graduate degree
- Numéro de téléphone: +84 17599456276
- E-mail: 1241332783@qq.com
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- (1) Possession of a valid nurse practicing license; (2) Clinical work experience of ≥ 1 year; (3) Provision of informed consent and voluntary participation in this study.
Exclusion Criteria:
- （1）Participants who withdrew from the study midway; （2）Those who had participated in similar emergency-rescue-related training recently (within the past 3 months).
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Autre
- Répartition: Non randomisé
- Modèle interventionnel: Affectation à un seul groupe
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Comparateur placebo: Conventional face-to-face training on emergency response to bioterrorist attacks
The control group received **conventional face-to-face training on emergency response to bioterrorist attacks**, including theoretical lectures and practical drills. |
This study focused on a training program for school nursing staff, with participants from the first cohort serving as the control group and those from the second cohort as the intervention group. A non-concurrent controlled experiment was conducted: the control group received traditional in-person training consisting of theoretical instruction and practical exercises, while the intervention group received training that combined theoretical instruction with a virtual simulation training platform developed for this study. |
|
Comparateur actif: Virtual simulation training for emergency response to bioterrorist attacks
The intervention group received theoretical lectures combined with **virtual simulation training for emergency response to bioterrorist attacks** developed in this study. |
This study focused on a training program for school nursing staff, with participants from the first cohort serving as the control group and those from the second cohort as the intervention group. A non-concurrent controlled experiment was conducted: the control group received traditional in-person training consisting of theoretical instruction and practical exercises, while the intervention group received training that combined theoretical instruction with a virtual simulation training platform developed for this study. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Biosafety incident response competence
Délai: From enrollment to the completion of the four-week training.
|
The training effect among nurses was evaluated using the self-developed biosecurity incident response competence scale of our research group, which covers four dimensions: biosecurity incident monitoring and early-warning competence, nursing management competence for biosecurity incidents, biosecurity knowledge readiness, and biosecurity infection-protection competence. |
From enrollment to the completion of the four-week training.
|
Collaborateurs et enquêteurs
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- K202509-01
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .